Montana Compounding Pharmacy Recalls Hyaluronidase Injectable Solution Due to Sterility Concerns
Montana Compounding Pharmacy is recalling Hyaluronidase Injectable Solution because FDA inspectors observed objectionable conditions that raised concerns about the product's sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The rubric specifies that FDA Class II recalls involving significant injury or property damage reports, or structural defects, are Severe. While the source does not explicitly report injuries, the 'Lack of Assurance of Sterility' for an injectable product is a significant safety hazard that aligns with the Severe classification for Class II recalls involving potential serious harm.
Plain-English summary
Montana Compounding Pharmacy in Missoula, MT, is recalling Hyaluronidase (RM ONLY), Injectable Solution, 150 U/mL, 10ML vials. The recall was initiated because FDA inspectors observed objectionable conditions during an inspection that raised a lack of assurance of sterility for the product.
The affected product is a prescription-only compounded injectable solution. The recall covers specific lots with expiry dates ranging from May 17, 2015, to June 30, 2015. The product was distributed in Montana and North Dakota.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions. The FDA classifies this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Hyaluronidase (RM ONLY), Injectable Solution, 150 U/mL, 10ML vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
- Manufacturer
- Montana Compounding Pharmacy
- Category
- Drug — Injectable Solution
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot 02062015:06@3
- expiry date: 5/17/2015
- Lot 02272015:93@1
- expiry date: 6/30/2015
- Lot 03252015:92@7
- Lot 04162015:63@7
- expiry date: 6/30/2015.
Distribution
Part of a larger recall action
This product is one of 12 recalled by Montana Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Montana Compounding Pharmacy
See all →- SevereMontana Compounding Pharmacy Recalls Trimix Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Nasal Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Alprostadil Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Trimix Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29